-
21
Unveiling Microbiota Profiles in Saliva and Pancreatic Tissues of Patients with Pancreatic Cancer
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
22
Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
23
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
24
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
25
Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy
Published 2025-04-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
26
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
27
-
28
Effects of NK cell-related lncRNA on the immune microenvironment and molecular subtyping for pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: Get full text
Article -
29
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2
Published 2025-01-01Subjects: “…Locally advanced pancreatic ductal adenocarcinoma (laPDAC)…”
Get full text
Article -
30
-
31
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
Published 2025-02-01Subjects: Get full text
Article -
32
Evaluation of Overall Survival Predictions In Inoperable Pancreas Ductal Adenocarcinoma
Published 2022-02-01Subjects: Get full text
Article